Blade beats Q2 revenue estimates, net loss narrows

Overview

• Blade Q2 2025 revenue rises 4.2%, beating analyst expectations, per LSEG data

• Net loss improves to $3.7 mln, adjusted EBITDA rises to $3.2 mln

• Co to sell Passenger division to Joby Aviation for up to $125 mln

Outlook

• Blade reaffirms 2025 revenue guidance of $245-265 mln

• Company expects divestiture to be EBITDA and cash flow neutral

• Strata to focus on organic growth and capital allocation

• Partnership with Joby Aviation to provide access to eVTOLs for medical flights

Result Drivers

• MEDICAL SEGMENT GROWTH - Medical revenue increased 17.6% year-over-year, driven by new customers and higher revenue per block hour

• PASSENGER SEGMENT DECLINE - Passenger revenue decreased due to exit from Canada and reduced demand in U.S. following a helicopter incident

• COST REDUCTIONS - Improved net loss driven by $7.2 mln improvement in loss from operations and higher non-operating income

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• Wall Street's median 12-month price target for Blade Air Mobility Inc is $6.00, about 26.2% above its August 4 closing price of $4.43

Press Release: ID:nGNX18jfhD